Literature DB >> 25160472

The influence of sex hormones on anterior cruciate ligament ruptures in males.

Lazar Stijak1, Marko Kadija2, Vuk Djulejić3, Milan Aksić4, Nataša Petronijević5, Dubravka Aleksić6, Vidosava Radonjić7, Marko Bumbaširević8, Branislav Filipović9.   

Abstract

PURPOSE: The purpose of this study is to determine the difference in the concentrations of testosterone, 17-β estradiol and progesterone between male patients with and without ACL rupture, as well as the possible effect of these hormones on generalized joint laxity.
METHODS: Male subjects with non-contact knee joint injury were included in this study. Two groups were formed: the examined group, consisting of subjects with ACL rupture and the control group consisting of patients without ACL rupture. After this, the patients from these two groups were paired off on the basis of three factors, level of professional involvement in sports (including the type of sports activity), left or right side of the body and the age of the subjects. In the end, there were 29 pairs (58 subjects). The concentration of sex hormones was determined from saliva specimens with the aid of the Salimetrics enzyme immunoassay. The testing of generalized joint laxity was performed with the aid of the "laxity score" according to Beighton et al.
RESULTS: Subjects with ACL rupture have highly statistically significantly greater concentrations of testosterone (p < 0.01), statistically significantly greater concentrations of 17-β estradiol (p < 0.05), and a highly statistically significantly greater generalized joint laxity score than subjects with an intact ACL (p < 0.01).
CONCLUSION: Increased concentrations of testosterone or 17-β estradiol may be a risk factor leading to ACL rupture. Also, generalized joint laxity may be a factor leading to ACL rupture, but none of the monitored hormones can be set down as the cause of its existence. Young male athletes with higher concentrations of testosterone and greater hyperelasticity should plan preventive programs of physiotherapy for ACL preservation since they present a vulnerable group susceptible to ACL rupture. LEVEL OF EVIDENCE: Diagnostic study, Level II.

Entities:  

Keywords:  17-β estradiol; Anterior cruciate ligament; Joint laxity; Progesterone; Testosterone

Mesh:

Substances:

Year:  2014        PMID: 25160472     DOI: 10.1007/s00167-014-3247-3

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  27 in total

1.  The relative incidence of anterior cruciate ligament injury in men and women at the United States Naval Academy.

Authors:  D E Gwinn; J H Wilckens; E R McDevitt; G Ross; T C Kao
Journal:  Am J Sports Med       Date:  2000 Jan-Feb       Impact factor: 6.202

2.  Gender differences in the validity of testosterone measured in saliva by immunoassay.

Authors:  Elizabeth A Shirtcliff; Douglas A Granger; Andrea Likos
Journal:  Horm Behav       Date:  2002-08       Impact factor: 3.587

3.  Effect of estrogen on cellular metabolism of the human anterior cruciate ligament.

Authors:  W D Yu; S H Liu; J D Hatch; V Panossian; G A Finerman
Journal:  Clin Orthop Relat Res       Date:  1999-09       Impact factor: 4.176

4.  Articular mobility in an African population.

Authors:  P Beighton; L Solomon; C L Soskolne
Journal:  Ann Rheum Dis       Date:  1973-09       Impact factor: 19.103

5.  Effect of testosterone on the female anterior cruciate ligament.

Authors:  Richard M Lovering; William A Romani
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-03-24       Impact factor: 3.619

6.  Primary immunolocalization of estrogen and progesterone target cells in the human anterior cruciate ligament.

Authors:  S H Liu; R al-Shaikh; V Panossian; R S Yang; S D Nelson; N Soleiman; G A Finerman; J M Lane
Journal:  J Orthop Res       Date:  1996-07       Impact factor: 3.494

7.  Estrogen and muscle stiffness have a negative relationship in females.

Authors:  David R Bell; J Troy Blackburn; Marc F Norcross; Kristin S Ondrak; Jeffery D Hudson; A C Hackney; Darin A Padua
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-06-22       Impact factor: 4.342

8.  Estrogen level alters the failure load of the rabbit anterior cruciate ligament.

Authors:  J Slauterbeck; C Clevenger; W Lundberg; D M Burchfield
Journal:  J Orthop Res       Date:  1999-05       Impact factor: 3.494

9.  Primary immunolocalization of androgen target cells in the human anterior cruciate ligament.

Authors:  W P Hamlet; S H Liu; V Panossian; G A Finerman
Journal:  J Orthop Res       Date:  1997-09       Impact factor: 3.494

10.  Estrogen receptor alpha mRNA in human skeletal muscles.

Authors:  Sophie Lemoine; Pascale Granier; Christophe Tiffoche; Francoise Rannou-Bekono; Marie-Lise Thieulant; Paul Delamarche
Journal:  Med Sci Sports Exerc       Date:  2003-03       Impact factor: 5.411

View more
  3 in total

1.  Correlation between quantitative pivot shift and generalized joint laxity: a prospective multicenter study of ACL ruptures.

Authors:  David Sundemo; Anna Blom; Yuichi Hoshino; Ryosuke Kuroda; Nicola Francesco Lopomo; Stefano Zaffagnini; Volker Musahl; James J Irrgang; Jón Karlsson; Kristian Samuelsson
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-11-17       Impact factor: 4.342

Review 2.  Generalised joint hypermobility increases ACL injury risk and is associated with inferior outcome after ACL reconstruction: a systematic review.

Authors:  David Sundemo; Eric Hamrin Senorski; Louise Karlsson; Alexandra Horvath; Birgit Juul-Kristensen; Jon Karlsson; Olufemi R Ayeni; Kristian Samuelsson
Journal:  BMJ Open Sport Exerc Med       Date:  2019-11-10

3.  Local controlled release of corticosteroids extends surgically induced joint instability by inhibiting tissue healing.

Authors:  Imke Rudnik-Jansen; Anna R Tellegen; Behdad Pouran; Karin Schrijver; Björn P Meij; Pieter J Emans; Erin de Gendt; Rachel E Thomas; Marja J L Kik; Huub M de Visser; Harrie Weinans; Annelies Egas; Erik van Maarseveen; Nina Woike; George Mihov; Jens Thies; Marianna A Tryfonidou; Laura B Creemers
Journal:  Br J Pharmacol       Date:  2019-10-08       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.